Filing Details
- Accession Number:
- 0001553023-20-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-17 18:45:16
- Reporting Period:
- 2020-06-16
- Accepted Time:
- 2020-06-17 18:45:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553023 | Cyrusone Inc. | CONE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311762 | M Robert Jackson | C/O Cyrusone Inc. 2850 N Harwood St Suite 2200 Dallas TX 75201-2640 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-16 | 11,445 | $36.99 | 35,923 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-06-16 | 12,719 | $30.74 | 48,642 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-16 | 24,164 | $75.39 | 24,478 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2020-06-16 | 11,445 | $0.00 | 11,445 | $36.99 |
| Common Stock | Stock Option | Disposition | 2020-06-16 | 12,719 | $0.00 | 12,719 | $30.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-02-01 | No | 4 | M | Direct | |
| 0 | 2025-07-31 | No | 4 | M | Direct |
Footnotes
- These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.16 to $75.55, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within such range.
- The option vested in three equal installments on February 1, 2017, 2018, and 2019.
- The option vested in three equal installments on July 31, 2016, 2017, and 2018.
Billionaire Hedge Funds
